📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
DCM Shriram Board to Meet Jan 20 for Q3 Results and 2nd Interim Dividend
DCM Shriram Limited has scheduled a board meeting on January 20, 2026, to approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The board will also consider the declaration of a second interim dividend for the financial year 2025-26. If approved, the company has already fixed January 24, 2026, as the record date for determining shareholder eligibility. The trading window for the company's equity shares is currently closed and will remain so until January 22, 2026.
Key Highlights
Board meeting scheduled for January 20, 2026, to discuss Q3 results and dividend.
Record date for the potential 2nd interim dividend is set for January 24, 2026.
Trading window remains closed from January 1 to January 22, 2026.
The meeting will cover both standalone and consolidated financial results for the nine-month period.
💼 Action for Investors
Investors should watch for the dividend amount and Q3 earnings performance on January 20. To be eligible for the dividend, ensure shares are held in the demat account by the record date of January 24.
DCM Ltd Settles ₹8.12 Crore VAT Dispute for ₹1.14 Crore Under Punjab OTS Scheme
DCM Limited has successfully concluded a long-standing VAT litigation with the Punjab Excise and Taxation Department for the period FY 2010-11 to 2013-14. Under the Punjab One Time Settlement Scheme (OTSS) 2025, the company settled a total demand of ₹8.12 crore, which included basic tax, interest, and penalties, for a final payment of ₹1.14 crore. As the company had already deposited ₹99 lakhs during the appeal process, the incremental cash outflow was minimal. This settlement effectively eliminates a significant contingent liability and prevents future interest accruals, cleaning up the company's balance sheet.
Key Highlights
Settled total tax demand of ₹811.67 lakhs (including interest and penalty) for a final amount of ₹113.89 lakhs.
The settlement covers four financial years from 2010-11 to 2013-14 regarding Entry Tax credit on High Speed Diesel (HSD).
Achieved full waiver of interest and penalties under the Punjab Government's OTSS 2025 notification.
Incremental cash outflow was limited as the company had already deposited ₹99 lakhs with the authorities previously.
Final settlement order received on December 30, 2025, resulting in the closure of all associated contingent liabilities.
💼 Action for Investors
Investors should view this as a positive development that removes legal uncertainty and financial risk at a fraction of the original demand. The management's decision to utilize the OTS scheme reflects prudent risk mitigation and balance sheet management.
DCM Shriram Industries Reconstitutes Board; Appoints New MD & CEO with Remuneration Hike
DCM Shriram Industries has announced a major board reconstitution following an NCLT-approved Scheme of Arrangement. Mr. Alok Bansidhar Shriram has resigned as Sr. MD & CEO, and Mr. Madhav Bansidhar Shriram has been redesignated as MD & CEO with a basic salary hike from Rs. 5.8 lakh to Rs. 7.5 lakh per month. Additionally, two new executive directors, Mr. Uday Shriram and Mr. Rohan Shriram, have been inducted to lead the restructured entity. The changes are part of a broader corporate reorganization involving the creation of two new resultant companies.
Key Highlights
Resignation of Mr. Alok Bansidhar Shriram (Sr. MD & CEO) and Mrs. Urvashi Tilakdhar (WTD) effective Dec 23, 2025.
Mr. Madhav Bansidhar Shriram redesignated as MD & CEO with basic salary increased to Rs. 7.5 lakh per month.
MD & CEO commission increased from up to 3% of PBT to up to 5% of PBT effective FY 2025-26.
Induction of Mr. Uday Shriram as Dy. Managing Director and Mr. Rohan Shriram as Whole Time Director.
Board changes implemented to facilitate the NCLT-approved Scheme of Arrangement involving three distinct corporate entities.
💼 Action for Investors
Investors should track the operational transition as the company implements its Scheme of Arrangement and monitor the performance of the new leadership team. The significant increase in MD remuneration and the induction of next-generation promoters suggest a long-term leadership transition.
DCM Shriram Industries Revises Record Date for Demerger to December 26, 2025
DCM Shriram Industries Limited has announced a revision in the record date for its corporate restructuring plan from December 19 to December 26, 2025. This restructuring involves the allotment of shares in two new entities: DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The delay is attributed to administrative formalities regarding the extinguishment and allotment of shares involving Lily Commercial Pvt. Limited. Shareholders holding the stock as of the new record date will be eligible for the share allotment in the resultant companies.
Key Highlights
Revised Record Date for the Scheme of Arrangement is now December 26, 2025.
The previous record date was set for December 19, 2025.
Entitlement includes shares in two new entities: DCM Shriram Fine Chemicals and DCM Shriram International.
Delay caused by pending formalities related to the transferor company, Lily Commercial Pvt. Limited.
💼 Action for Investors
Investors interested in receiving shares of the two demerged entities must ensure they hold the stock until the revised record date of December 26, 2025. No immediate action is required other than noting the one-week delay in the process.
DCM Shriram and Bayer Crop Science Sign Strategic MoU for Sustainable Agriculture
DCM Shriram Limited has signed a Memorandum of Understanding (MoU) with Bayer Crop Science Limited to jointly explore opportunities in India's agriculture ecosystem. The partnership focuses on agri-inputs, digital advisory, seeds, and specialty plant nutrition, leveraging Bayer's global R&D and DCM Shriram's extensive rural footprint. The collaboration also extends to exploring synergies in the chemicals business and sustainable initiatives like carbon sequestration. This strategic alliance aims to enhance farmer productivity and create long-term value through integrated crop management solutions.
Key Highlights
Strategic MoU signed on December 10, 2025, to advance sustainable and future-ready agriculture.
Collaboration covers agri-inputs, digital tools, seeds, specialty plant nutrition, and biologicals.
Companies to evaluate joint opportunities in select areas of the chemicals business.
Focus on soil health, carbon sequestration, and integrated crop management pilots.
Combines Bayer's global expertise with DCM Shriram's deep rural engagement and manufacturing capabilities.
💼 Action for Investors
This partnership with a global leader like Bayer is a significant positive for DCM Shriram's agri-business segment. Investors should monitor for specific product launches or revenue-generating projects resulting from this collaboration over the next few quarters.
DCM Shriram Industries: Record Date for Scheme of Arrangement is 19-Dec-2025
DCM Shriram Industries Limited announced a record date of December 19, 2025, for the Composite Scheme of Arrangement. Shareholders will receive one fully paid-up share of ₹2 in each of the two resultant companies, DCM Shriram Fine Chemicals (DSFCL) and DCM Shriram International Limited (DSIL), for every share held in DCM Shriram Industries. The equity shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1. This follows the NCLT's sanction of the scheme involving Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
Key Highlights
Record date is 19-Dec-2025 for the Composite Scheme of Arrangement.
Shareholders receive one share in each of DSFCL and DSIL for every share in DCM Shriram Industries.
Equity Shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1.
Scheme involves Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
💼 Action for Investors
Shareholders should note the record date of December 19, 2025, to be eligible for the share allocation in DCM Shriram Fine Chemicals and DCM Shriram International. Monitor further announcements regarding the scheme's effectiveness after filing with the Registrar of Companies.
DCM Shriram Industries Appoints Anurag Surana and Sidharth Prasad as Independent Directors
DCM Shriram Industries has appointed Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective December 10, 2025. Mr. Surana brings over 35 years of experience in the chemical industry, including a 20-year tenure at PI Industries where he served as Executive Director for 14 years. Mr. Prasad adds significant expertise in the sugar and energy sectors, currently serving on the board of L.H. Sugar Factories which operates a 12,500 TCD crushing capacity. These appointments are expected to strengthen the board's strategic oversight in the company's core business segments.
Key Highlights
Appointment of Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective Dec 10, 2025
Mr. Surana has 35+ years of experience in agrochemicals and was an Executive Director at PI Industries for 14 years
Mr. Prasad manages sugar operations with 12,500 TCD crushing and 160 KLPD ethanol production capacity
Both directors confirmed they are not debarred from holding office by SEBI or any other authority
The appointments aim to enhance board expertise in chemicals, sugar, and strategic growth
💼 Action for Investors
Investors should view these appointments as a positive move to bring in seasoned industry veterans to the board. The addition of a former PI Industries leader is particularly noteworthy for the company's chemical business prospects.